Corvus Pharmaceuticals Inc
SWB:C17
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Corvus Pharmaceuticals Inc
SWB:C17
|
US |
|
MS&AD Insurance Group Holdings Inc
F:59M0
|
JP |
|
S
|
SeA Mechanics Co Ltd
KOSDAQ:396300
|
KR |
|
T
|
TAG Immobilien AG
F:TEG
|
DE |
|
N
|
New Bubbleroom Sweden AB
F:K3N
|
SE |
|
G
|
Green River Gold Corp
CNSX:CCR
|
CA |
|
N
|
National Australia Bank Ltd
DUS:NAL
|
AU |
|
Jibannet Holdings Co Ltd
TSE:6072
|
JP |
|
B
|
BHP Group Ltd
JSE:BHG
|
AU |
|
G
|
Gen Digital Inc
XHAN:SYM
|
US |
|
Orrstown Financial Services Inc
NASDAQ:ORRF
|
US |
|
M
|
Mitra Adiperkasa Tbk PT
OTC:PMDKF
|
ID |
|
C
|
CITIC Ltd
XMUN:CPF
|
CN |
|
Copper Fox Metals Inc
F:HPU
|
CA |
|
K
|
Kendrion NV
F:K3E
|
NL |
|
E
|
Eni SpA
F:ENI1
|
IT |
|
Fluidra SA
MAD:FDR
|
ES |
|
B
|
BITComputer
KOSDAQ:032850
|
KR |
|
T
|
Trans Polonia SA
WSE:TRN
|
PL |
|
First Class Metals PLC
OTC:FCMXF
|
UK |
|
D
|
Deneb Investments Ltd
JSE:DNB
|
ZA |
|
S
|
Springvest Oyj
OMXH:SPRING
|
FI |
|
P
|
Polight ASA
OSE:PLT
|
NO |
|
E
|
Evoke PLC
XMUN:C8V
|
GI |
Bankruptcy Probability
Corvus Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Corvus Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Corvus Pharmaceuticals Inc
NASDAQ:CRVS
|
895.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
504B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
242B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
195.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
135.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
80.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
57.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Corvus Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Corvus Pharmaceuticals Inc has no debt.
You can find a full breakdown on its Balance Sheet.